Diagnostica Stago

Diagnostica Stago
Name	Diagnostica Stago
Type	Private
Founded	1969
Founder	Jean-Pierre Ortlieb
Headquarters	Asnières-sur-Seine, France
Industry	In vitro diagnostics
Products	Hemostasis analyzers, reagents

Diagnostica Stago is a French company specializing in diagnostic systems for hemostasis and thrombosis, with a legacy in coagulation testing, laboratory instruments, and reagent development. The firm has engaged with clinical laboratories, hospitals, and research institutions across Europe, North America, and Asia, collaborating with manufacturers, universities, and regulatory agencies to deploy automated analyzers and quality controls. Diagnostica Stago’s activities intersect with fields and institutions such as hematology, cardiovascular medicine, oncology, and transplantation, interacting with major healthcare stakeholders and certification bodies.

History

Founded in 1969 by Jean-Pierre Ortlieb, the company developed amid advances in laboratory automation and clinical hematology, alongside contemporaries such as Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Beckman Coulter, and Sysmex. During the 1970s and 1980s it expanded reagent portfolios and partnered with hospital laboratories affiliated with institutions like Hôpital Cochin, Hospital for Special Surgery, Johns Hopkins Hospital, and Mayo Clinic. In the 1990s and 2000s Diagnostica Stago navigated consolidation in the diagnostics sector, competing and collaborating with firms including Thermo Fisher Scientific, Ortho Clinical Diagnostics, Medtronic, and Becton Dickinson while responding to standards from bodies such as European Medicines Agency, U.S. Food and Drug Administration, and International Organization for Standardization. Recent decades saw strategic alliances and distribution agreements with regional players in markets involving Siemens, Bio-Rad Laboratories, Horiba, Fisher Scientific, and academic collaborations with universities like Université Paris Cité, Harvard University, and Imperial College London.

Products and technologies

Diagnostica Stago produces coagulation analyzers, thrombophilia panels, anticoagulant monitoring assays, and associated reagents and controls, operating in the same product space as systems from ACL (instrument), STA-R Evolution, STA Compact, and shared workflows with instruments made by Roche Cobas, Siemens Advia, and Beckman Coulter AU series. Their reagents include assays for prothrombin time, activated partial thromboplastin time, fibrinogen, D-dimer, and factor assays used in clinical protocols at centers like Cleveland Clinic, Massachusetts General Hospital, and Guy's and St Thomas' NHS Foundation Trust. The firm integrates automation and middleware interoperability with laboratory information systems developed by vendors such as Cerner Corporation, Epic Systems, Sunquest Information Systems, and Sartorius Stedim Biotech, enabling workflows used in transfusion services at institutions including American Red Cross and blood banks modeled on NHS Blood and Transplant.

Research and development

R&D efforts have focused on assay chemistry, reagent stability, point-of-care coagulation testing, and biomarker discovery, with collaborations involving research centers like INSERM, CNRS, Karolinska Institutet, and The Scripps Research Institute. Clinical validation studies have been published alongside investigators from Stanford University, University of Oxford, University of Cambridge, and McGill University, and have interfaced with clinical trials registered with agencies such as European Clinical Trials Database and oversight by World Health Organization guidelines. Technological innovation has drawn on partnerships with biotechnology firms such as Genentech, Novartis, Pfizer, and device innovators including Medtronic for perioperative coagulation monitoring and with anticoagulant therapy centers like American College of Cardiology and European Society of Cardiology for guideline-aligned assay development.

Manufacturing and facilities

Manufacturing and assembly operations are located in France with distribution hubs in regions served by logistics partners like DHL, UPS, and FedEx Corporation, while contract manufacturing and component sourcing have involved suppliers in Germany, Switzerland, and the United States such as BASF, Bayer, and Lonza. Production quality systems are aligned with standards promulgated by ISO 13485, and facilities often interact with certification bodies including TÜV SÜD and BSI Group. Supply chain relationships include raw-material and consumables providers used by firms like Thermo Fisher Scientific and Merck Group (Merck KGaA).

Market presence and partnerships

Diagnostica Stago maintains market share in hemostasis diagnostics across Europe, Latin America, Asia-Pacific, and North America, working through distributors and partners such as Cardinal Health, Henry Schein, Fresenius Medical Care, and regional groups like Cofares and Sinopharm Group. Strategic partnerships have been announced with academic hospitals, national reference laboratories, and international societies such as International Society on Thrombosis and Haemostasis, European Hematology Association, and patient advocacy organizations including American Heart Association and British Heart Foundation for education and guideline dissemination.

Regulations and quality assurance

Product registration and post-market surveillance comply with regulatory frameworks under European Union Medical Device Regulation, U.S. Food and Drug Administration premarket submissions, and conformity assessment by notified bodies recognized across the European Commission regulatory network. Quality assurance leverages proficiency testing programs run by organizations such as College of American Pathologists, UK National External Quality Assessment Service, and European Directorate for the Quality of Medicines & HealthCare, and adheres to standards from International Organization for Standardization and guidelines from clinical authorities like French National Authority for Health.

Corporate structure and ownership

Historically privately held, the company’s ownership and governance have involved executive leadership and board oversight interfacing with investors and partners such as private equity firms common in the sector including EQT (investment firm), Permira, and corporate entities like Shire plc or Sanofi in comparable M&A activity. Executive management engages with industry associations including European Diagnostic Manufacturers Association and trade events such as Medica Trade Fair and AACC Annual Scientific Meeting & Clinical Lab Expo.

Philanthropy and corporate social responsibility

Corporate social responsibility initiatives have included support for clinical education, training programs at universities like Université Paris-Saclay and University of Barcelona, donations to global health programs coordinated by Médecins Sans Frontières, Red Cross, and collaborations with non-profits such as Bill & Melinda Gates Foundation and World Federation of Hemophilia to improve access to diagnostics in low-resource settings. Environmental and sustainability efforts align with frameworks from United Nations Environment Programme and reporting standards associated with Global Reporting Initiative.

Category:Medical technology companies of France